P/E ratio for OncoSec (ONCS)
P/E ratio as of May 2024 (TTM): -0.0171
According to OncoSec's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.0170958. At the end of 2022 the company had a P/E ratio of -0.8506.
P/E ratio history for OncoSec from 2011 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.8506 | -46.55% |
| 2021 | -1.59 | -6.57% |
| 2020 | -1.70 | 227.64% |
| 2019 | -0.5198 | -59.78% |
| 2018 | -1.29 | 31.72% |
| 2017 | -0.9811 | -13.08% |
| 2016 | -1.13 | -69.1% |
| 2015 | -3.65 | -48.86% |
| 2014 | -7.14 | 77.25% |
| 2013 | -4.03 | -26.73% |
| 2012 | -5.50 | -66.67% |
| 2011 | -16.5 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.